Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2

Status

Completed 22Terminated 7Unknown 4Withdrawn 1Approved for marketing 1

Sponsor Class

NIH 2NETWORK 2

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 2Gastrointestinal 1CNS 1

Conditions

Prostatic Neoplasms 1Liver Neoplasms 1Kidney Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1

Interventions

Cisplatin 517Radiotherapy 378Cyclophosphamide 368Carboplatin 359Capecitabine 342Paclitaxel 337Oxaliplatin 336Gemcitabine 322Docetaxel 317Fluorouracil 291Drug Therapy 277Bevacizumab 249apatinib 247camrelizumab 219Etoposide 201Irinotecan 183Doxorubicin 181Leucovorin 164Dexamethasone 161pembrolizumab 155Neoadjuvant Therapy 146sintilimab 145anlotinib 140Blood Specimen Collection 140Pemetrexed 138Cytarabine 138toripalimab 133Surgical Procedures, Operative 131Radiosurgery 131S 1 (combination) 125

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × motexafin gadolinium × Clear all
NCT01082224 2023-07-07

ACRIN6690

American College of Radiology Imaging Network

Phase NA Unknown
440 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT01562223 2021-10-18

A6701QIBA

American College of Radiology Imaging Network

Phase NA Unknown
30 enrolled
Genitourinary

Prostatic Neoplasms

NCT00717587 2014-01-10

Sunitinib Before and After Surgery in Treating Patients With Stage IV Kidney Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
20 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00514397 2013-08-12

Temozolomide and Radiation Therapy in Treating Young Patients With Pontine Glioma

National Cancer Institute (NCI)

Phase 2 Unknown
43 enrolled
CNS

Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡